FCPM III Services B.V.

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), FCPM III Services B.V. reported 7 stock positions worth $582.3 million. Its top holding was Dyne Therapeutics (DYN) at 36.7% of the portfolio, followed by Newamsterdam Pharma (NAMS, 33.7%) and Engene (ENGN, 9.8%). Compared with Q2 2024, it added to 1 and reduced 1. The biggest buy was Bicycle Therapeutics PLC-ADR (BCYC, shares +10%) and the biggest sale Dyne Therapeutics (DYN, shares −24%).

Most Recent 13F
Q2 2026
Location
NAARDEN, P7
CIK
0002013410
Portfolio Value
$582.3M (Q3 2024)
SEC Filing
0000950123-24-011523 ↗ filed Nov 14, 2024

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q1 2024: $707.3M Q1 2024 Q2 2024: $678.1M Q2 2024 Q3 2024: $582.3M $582.3M Q3 2024 Q4 2024: $592.4M Q4 2024 Q1 2025: $413.7M Q1 2025 Q2 2025: $369.2M Q2 2025 Q3 2025: $500.4M Q3 2025 Q4 2025: $762.9M Q4 2025 Q1 2026: $722.2M Q1 2026 Q2 2026: $750.4M Q2 2026

Holdings 7 stocks · $582.3M

DYN Dyne Therapeutics Inc. 36.73% 5,954,069 $213.9M Reduce -24.1%
NAMS Newamsterdam Pharma Co. NV 33.73% 11,831,461 $196.4M No change
ENGN Engene Holdings Inc. 9.84% 8,677,951 $57.3M No change
REPL Replimune Group Inc. 9.16% 4,866,449 $53.3M No change
BCYC Bicycle Therapeutics PLC-ADR 9.09% 2,339,961 $53.0M Add +10.2%
ENGENE HOLDINGS INC 1.04% 2,878,148 $6.0M No change
ACHL Achilles Therapeutics PL-ADR 0.42% 2,390,050 $2.4M No change

Portfolio Sells Q2 2024 → Q3 2024

DYN Dyne Therapeutics Inc. Reduce -24.1% 36.73% −4.10

Portfolio Buys Q2 2024 → Q3 2024

BCYC Bicycle Therapeutics PLC-ADR Add +10.2% 9.09% +2.76

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 11$750.4MNAMS, MPLT, DYN, VOR, DMRA
Q1 2026 10$722.2MNAMS, DYN, VOR, ENGN, MPLT
Q4 2025 10$762.9MNAMS, DYN, ENGN, RAPT, MPLT
Q3 2025 9$500.4MNAMS, DYN, ENGN, ATXS, BCYC
Q2 2025 8$369.2MNAMS, DYN, REPL, ENGN, BCYC
Q1 2025 7$413.7MNAMS, DYN, ENGN, REPL, BCYC
Q4 2024 8$592.4MNAMS, DYN, ENGN, BCYC, REPL
Q3 2024 7$582.3MDYN, NAMS, ENGN, REPL, BCYC
Q2 2024 7$678.1MDYN, NAMS, ENGN, REPL, BCYC
Q1 2024 6$707.3MNAMS, DYN, ENGN, REPL, ENGENE HOLDINGS INC